Listar por autor "Talavera, Pedro"

Mostrando ítems 1-2 de 2

    • Diastolic dysfunction following anthracycline-based chemotherapy in breast cancer patients: incidence and predictors 

      Serrano, José M.; González, Iria; Castillo, Silvia del; Muñiz, Javier; Morales, Luis J.; Moreno, Fernando; Jiménez, Rosa; Cristóbal, Carmen; Graupner, Catherine; Talavera, Pedro; Curcio, Alejandro; Martínez, Paula; Guerra, Juan A.; Alonso, Joaquin J (AlphaMed Press, 2015-07-16)
      [Abstract] INTRODUCTION: Cardiotoxicity represents a major limitation for the use of anthracyclines or trastuzumab in breast cancer patients. Data from longitudinal studies of diastolic dysfunction (DD) in this group ...

    • Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors 

      Serrano, José M.; Mata, Rebeca; González, Iria; Del Castillo, Silvia; Muñiz, Javier; Morales, Luis J.; Espinosa, María Jesús; Moreno, Fernando; Jiménez, Rosa; Cristóbal, Carmen; Graupner, Catherine; Talavera, Pedro; Gutiérrez Landaluce, Carlos; Curcio, Alejandro; Alonso, Javier; Guerra, Juan A.; Alonso, Joaquín J. (Elsevier, 2023-04-18)
      [Abstract] Introduction. Cardiotoxicity represents a major limitation for the use of anthracyclines or trastuzumab in breast cancer patients. Data on longitudinal studies about early and late onset cardiotoxicity in this ...